A5058544644- Cardiac Imaging and Diagnostics
- Sarcoidosis and Beryllium Toxicity Research
- Cardiovascular Function and Risk Factors
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Advanced MRI Techniques and Applications
- Medical Imaging Techniques and Applications
- Coronary Interventions and Diagnostics
- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Advanced X-ray and CT Imaging
- Amyloidosis: Diagnosis, Treatment, Outcomes
- COVID-19 Clinical Research Studies
- Cardiac Structural Anomalies and Repair
- Acute Myocardial Infarction Research
- Viral Infections and Immunology Research
- Radiomics and Machine Learning in Medical Imaging
- Atrial Fibrillation Management and Outcomes
- Medical Imaging and Pathology Studies
- Vasculitis and related conditions
- Mechanical Circulatory Support Devices
- Long-Term Effects of COVID-19
- SARS-CoV-2 and COVID-19 Research
- Pericarditis and Cardiac Tamponade
- Cardiac Arrhythmias and Treatments
- Heart Failure Treatment and Management
Juntendo University
2024-2025
Icahn School of Medicine at Mount Sinai
2020-2024
Jichi Medical University
2020-2024
Cardiovascular Center Hokkaido Ohno Hospital
2021-2024
Jichi Medical University Saitama Medical Center
2020-2024
Juntendo University Urayasu Hospital
2023-2024
Juntendo University Hospital
2024
Montefiore Medical Center
2024
Zero to Three
2024
Hokkaido University
2015-2021
Background To investigate the individual profile of each SGLT2 (sodium‐glucose cotransoporter‐2) inhibitor in patients with different backgrounds. Methods and Results This study included 21 placebo‐controlled randomized controlled trials a total 96 196 participants, investigating empagliflozin, ertugliflozin, dapagliflozin, canagliflozin, sotagliflozin. The primary efficacy end point was composite cardiovascular death hospitalizations for heart failure. secondary points were all‐cause death,...
Diastolic dysfunction is important in the pathophysiology of heart failure with preserved ejection fraction (HFpEF). Sympathetic nervous hyperactivity may contribute to development diastolic dysfunction. The aim this study was determine relationship between myocardial sympathetic innervation quantified by <sup>11</sup>C-hydroxyephedrine PET and HFpEF patients. <b>Methods:</b> Forty-one patients having an echocardiographic left ventricular 40% or greater 12 age-matched volunteers without...
Coronary flow reserve (CFR) is an integrated measure of the entire coronary vasculature, and a powerful prognostic marker in artery disease (CAD). The extent to which revascularization can improve CFR unclear. This study aimed evaluate impact percutaneous intervention (PCI) bypass grafting (CABG) on patients with stable CAD.In prospective, multicentre observational study, was measured by 15O-water positron emission tomography as ratio stress rest myocardial blood at baseline 6 months after...
Abstract Aims The prognostic implication of left ventricular outflow tract velocity time integral (LVOT‐VTI) on admission in hospitalized heart failure with preserved ejection fraction (HFpEF) patients has not been determined. We sought to investigate whether LVOT‐VTI is associated worse clinical outcomes HFpEF. Methods and results studied consecutive 214 HFpEF who had accessible data admission, from a prospective HFpEF‐specific multicentre registry. primary outcome interest was the...
Myocardial perfusion imaging without and with quantitative myocardial blood flow (MBF) reserve (MFR) plays an important role in the diagnosis risk stratification of patients stable coronary artery disease (CAD). We aimed to quantify effects revascularization on regional stress MBF MFR determine whether presence subendocardial infarction was associated these changes.Forty-seven CAD were prospectively enrolled. They underwent 15O-water positron emission tomography at baseline 6 months after...